Quality-of-Life Determinants in People with Diabetes Mellitus in Europe
Abstract
:1. Introduction
2. Materials and Methods
2.1. Sample
2.2. Study Variables
2.3. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Obucina, M.; Harris, N.; Fitzgerald, J.A.; Chaia, A.; Radforda, K.; Rossc, A.; Carrc, L.; Vecchioa, N. The application of triple aim framework in the context of primary healthcare: A systematic literature review. Health Policy 2018, 122, 900–907. [Google Scholar] [CrossRef] [PubMed]
- Smith-Palmer, J.; Bae, J.P.; Boye, K.S.; Norrbacka, K.; Hunt, B.; Valentine, W.J. Evaluating health-related quality of life in type 1 diabetes: A systematic literature review of utilities for adults with type 1 diabetes. Clin. Outcomes Res. 2016, 8, 559–571. [Google Scholar] [CrossRef] [Green Version]
- Saeedi, P.; Petersohn, I.; Salpea, P.; Malanda, B.; Karuranga, S.; Unwin, N.; Colagiuri, S.; Guariguata, L.; Motala, A.A.; Ogurtsova, K.; et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes Res. Clin. Pract. 2019, 157, 107843. [Google Scholar] [CrossRef] [Green Version]
- Cho, N.H.; Shaw, J.E.; Karuranga, S.; Huanga, Y.; da Fernandes, J.D.; Ohlrogge, A.W.; Malanda, B. IDF diabetes atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res. Clin. Pract. 2018, 138, 271–281. [Google Scholar] [CrossRef] [PubMed]
- International Diabetes Federation. IDF Diabetes Atlas Ninth Edition 2019. Available online: http://www.idf.org/about-diabetes/facts-figures (accessed on 15 March 2021).
- Barile, J.P.; Reeve, B.B.; Smith, A.W.; Zack, M.M.; Mitchell, S.A.; Kobau, R.; Cella, D.F.; Luncheon, C.; Thompson, W.W. Monitoring population health for Healthy People 2020: Evaluation of the NIH PROMIS® Global Health, CDC Healthy Days, and satisfaction with life instruments. Qual. Life Res. 2013, 22, 1201–1211. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tamayo, T.; Rosenbauer, J.; Wild, S.H.; Spijkerman, A.M.W.; Baan, C.; Forouhi, N.G.; Herder, C.; Rathmann, W. Diabetes in Europe: An update. Diabetes Res. Clin. Pract. 2014, 103, 206–217. [Google Scholar] [CrossRef] [PubMed]
- Kyrou, I.; Tsigos, C.; Mavrogianni, C.; Cardon, G.; van Stappen, V.; Latomme, J.; Kivelä, J.; Wikström, K.; Tsochev, K.; Nanasi, A.; et al. Sociodemographic and lifestyle-related risk factors for identifying vulnerable groups for type 2 diabetes: A narrative review with emphasis on data from Europe. BMC Endocr. Disord. 2020, 20 (Suppl. 1), 1–13. [Google Scholar] [CrossRef] [Green Version]
- Martínez-Vizcaíno, V.; Sánchez-López, M. Relación entre actividad física y condición física en niños y adolescentes. Rev. Española. Cardiol. 2008, 61, 108–111. [Google Scholar] [CrossRef]
- Yamaoka, K.; Tango, T. Efficacy of lifestyle education to prevent type 2 diabetes. Diabetes Care 2005, 28, 2780–2786. [Google Scholar] [CrossRef] [Green Version]
- Ekelund, U.; Brage, S.; Griffin, S.J.; Wareham, N.J. Objectively measured moderate- and vigorous-intensity physical activity but not sedentary time predicts insulin resistance in high-risk individuals diabetes care. Diabetes Care 2009, 32, 1081–1086. [Google Scholar] [CrossRef] [Green Version]
- Knowler, W.C.; Barrett-Connor, E.; Fowler, S.E.; Hamman, R.F.; Lachin, J.M.; Walker, E.A.; Nathan, D.M. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 2002, 346, 393–403. [Google Scholar] [CrossRef] [PubMed]
- Hemmingsen, B.; Gimenez-Perez, G.; Mauricio, D.; Roqué, I.; Figuls, M.; Metzendorf, M.-I.; Richter, B. Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database Syst. Rev. 2017, 12, CD003054. [Google Scholar] [CrossRef] [Green Version]
- Lustman, P.J.; Clouse, R.E. Depression in diabetic patients: The relationship between mood and glycemic control. J. Diabetes Complicat. 2005, 19, 113–122. [Google Scholar] [CrossRef]
- Williams, M.M.; Clouse, R.E.; Lustman, P.J. Treating Depression to prevent diabetes and its complications: Understanding depression as a medical risk factor. Clin. Diabetes 2006, 24, 79–86. [Google Scholar] [CrossRef] [Green Version]
- Knol, M.J.; Twisk, J.W.R.; Beekman, A.T.F.; Heine, R.J.; Snoek, F.J.; Pouwer, F. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia 2006, 49, 837. [Google Scholar] [CrossRef] [Green Version]
- Khetan, A.K.; Rajagopalan, S. Prediabetes. Can. J. Cardiol. 2018, 34, 615–623. [Google Scholar] [CrossRef]
- Paulweber, B.; Valensi, P.; Lindström, J.; Lalic, N.M.; Greaves, C.J.; McKee, M.; Kissimova-Skarbek, K.; Liatis, S.; Cosson, E.; Szendroedi, J.; et al. A European evidence-based guideline for the prevention of type 2 diabetes. Horm. Metab. Res. 2010, 42, S3–S36. [Google Scholar] [CrossRef] [Green Version]
- Koetsenruijter, J.; van Lieshout, J.; Vassilev, I.; Portillo, M.C.; Serrano, M.; Knutsen, I.; Roukova, P.; Lionis, C.; Todorova, E.; Foss, C.; et al. Social support systems as determinants of self-management and quality of life of people with diabetes across Europe: Study protocol for an observational study. Health Qual. Life Outcomes 2014, 12, 29. [Google Scholar] [CrossRef] [Green Version]
- Carmienke, S.; Baumert, J.; Gabrys, L.; Heise, M.; Frese, T.; Heidemann, C.; Fink, A. Participation in structured diabetes mellitus self-management education program and association with lifestyle behavior: Results from a population-based study. BMJ Open Diabetes Res. Care 2020, 8, e001066. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kuznetsov, L.; Long, G.H.; Griffin, S.J.; Simmons, R.K. Are changes in glycaemic control associated with diabetes-specific quality of life and health status in screen-detected type 2 diabetes patients? Four-year follow up of the ADDITION-Cambridge cohort. Diabetes Metab. Res. Rev. 2015, 31, 69–75. [Google Scholar] [CrossRef] [PubMed]
- European Health Interview Survey (EHIS Wave 2); Eurostat—European Union: Luxembourg, 2015. [CrossRef]
- Gómez-Beneyto, M.; Nolasco, A.; Moncho, J.; Pereyra-Zamora, P.; Tamayo-Fonseca, N.; Munarriz, M.; Salazar, J.; Tabarés-Seisdedos, R.; Girón, M. Psychometric behaviour of the strengths and difficulties questionnaire (SDQ) in the Spanish national health survey 2006. BMC Psychiatry 2013, 13, 95. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kaminska, O.; Lynn, P. Survey-based cross-country comparisons where countries vary in sample design: Issues and solutions. J. Off. Stat. 2017, 33, 123–136. [Google Scholar] [CrossRef] [Green Version]
- Glechner, A.; Harreiter, J.; Gartlehner, G.; Rohleder, S.; Kautzky, A.; Tuomilehto, J.; van Noord, M.; Kaminski-Hartenthaler, A.; Kautzky-Willer, A. Sex-specific differences in diabetes prevention: A systematic review and meta-analysis. Diabetologia 2015, 58, 242–254. [Google Scholar] [CrossRef] [Green Version]
- DECODE Study Group. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 2003, 26, 61–69. [Google Scholar] [CrossRef] [Green Version]
- DECODE Study Group. Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts. Diabetes Care 2003, 26, 1770–1780. [Google Scholar] [CrossRef] [Green Version]
- Li, X.; Jiao, Y.; Xing, Y.; Gao, P. Diabetes mellitus and risk of hepatic fibrosis/cirrhosis. BioMed Res. Int. 2019, 2019, 5308308. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Agardh, E.; Allebeck, P.; Hallqvist, J.; Moradi, T.; Sidorchuk, A. Type 2 diabetes incidence and socio-economic position: A systematic review and meta-analysis. Int. J. Epidemiol. 2011, 40, 804–818. [Google Scholar] [CrossRef] [Green Version]
- Katzmarzyk, P.T. Physical fitness and risk for type 2 diabetes mellitus: Reducing risk at any weight. Ann. Intern. Med. 2016, 164, 620–621. [Google Scholar] [CrossRef]
- Smith, A.D.; Crippa, A.; Woodcock, J.; Brage, S. Physical activity and incident type 2 diabetes mellitus: A systematic review and dose–response meta-analysis of prospective cohort studies. Diabetologia 2016, 59, 2527–2545. [Google Scholar] [CrossRef] [Green Version]
- Fernandez-Navarro, P.; Aragones, M.T.; Ley, V. Leisure-time physical activity and prevalence of non-communicable pathologies and prescription medication in Spain. PLoS ONE 2018, 13, e0191542. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Weickert, M.O.; Pfeiffer, A.F.H. Impact of dietary fiber consumption on insulin resistance and the prevention of type 2 diabetes. J. Nutr. 2018, 148, 7–12. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Leatherdale, S.T.; Laxer, R.E. Reliability and validity of the weight status and dietary intake measures in the COMPASS questionnaire: Are the self-reported measures of body mass index (BMI) and Canada’s food guide servings robust? Int. J. Behav. Nutr. Phys. Act. 2013, 10, 42. [Google Scholar] [CrossRef] [Green Version]
- Rizza, S.; Clementi, F.; Porzio, O.; Cardellini, M.; Savo, A.; Serino, M.; Chiricolo, G.; Romeo, F.; Lauro, R.; Federici, M. Adiponectin isoforms are not associated with the severity of coronary atherosclerosis but with undiagnosed diabetes in patients affected by stable CAD. Nutr. Metab. Cardiovasc. Dis. 2009, 19, 54–60. [Google Scholar] [CrossRef] [PubMed]
- Rizza, S.; Cardellini, M.; Martelli, E.; Porzio, O.; Pecchioli, C.; Nicolucci, A.; Marx, N.; Lauro, D.; Ippoliti, A.; Romeo, F.; et al. Occult impaired glucose regulation in patients with atherosclerosis is associated to the number of affected vascular districts and inflammation. Atherosclerosis 2010, 212, 316–320. [Google Scholar] [CrossRef] [PubMed]
Health Status Variables | No Diabetes | Diabetes | |||
---|---|---|---|---|---|
n | % | n | % | p Value | |
Self-perceived general health | |||||
Very good | 74,216 | 25,4 | 613 | 3.0 | <0.001 |
Good | 130,289 | 44.6 | 4884 | 24.0 | |
Fair | 58,745 | 20.1 | 8894 | 43.7 | |
Bad | 15,020 | 5.1 | 4194 | 20.6 | |
Very bad | 3707 | 1.3 | 1203 | 5.9 | |
Don’t know/refusal | 9844 | 3.4 | 562 | 2.8 | |
Long-standing health problem (duration ≥ 6 months) | |||||
No | 17,1603 | 58.8 | 1612 | 7.9 | <0.001 |
Yes | 116,518 | 39.9 | 18,499 | 90.9 | |
Don’t know/refusal | 3700 | 1.3 | 240 | 1.2 | |
COPD in the past 12 months | |||||
No | 281,369 | 96.4 | 17,805 | 87.5 | <0.001 |
Yes | 9659 | 3.3 | 2108 | 10.4 | |
Don’t know/refusal | 794 | 0.3 | 437 | 2.1 | |
MI/chronic consequences of MI * | |||||
No | 287,497 | 98.5 | 18,520 | 91.0 | <0.001 |
Yes | 3521 | 1.2 | 1374 | 6.8 | |
Don’t know/refusal | 804 | 0.3 | 457 | 2.2 | |
Coronary heart disease/angina pectoris * | |||||
No | 282,345 | 96.8 | 17,257 | 84.8 | <0.001 |
Yes | 8616 | 3.0 | 2657 | 13.1 | |
Don’t know/refusal | 861 | 0.3 | 436 | 2.1 | |
Hypertension * | |||||
No | 238,080 | 81.6 | 8237 | 40.5 | <0.001 |
Yes | 53,366 | 18.3 | 11,973 | 58.8 | |
Don’t know/refusal | 376 | 0.1 | 140 | 0.7 | |
Stroke/chronic consequences of stroke * | |||||
No | 287,724 | 98.6 | 18,902 | 92.9 | <0.001 |
Yes | 3257 | 1.1 | 982 | 4.8 | |
Don’t know/refusal | 841 | 0.3 | 466 | 2.3 | |
Cirrhosis of the liver * | |||||
No | 290,731 | 99.6 | 19,570 | 96.2 | <0.001 |
Yes | 869 | 0.3 | 353 | 1.7 | |
Don’t know/refusal | 222 | 0.1 | 427 | 2.1 | |
Kidney problems * | |||||
No | 284,834 | 97.6 | 18,040 | 88.6 | <0.001 |
Yes | 6726 | 2.3 | 1912 | 9.4 | |
Don’t know/refusal | 262 | 0.1 | 398 | 2.0 | |
Depression * | |||||
No | 272,173 | 93.3 | 17,226 | 84.6 | <0.001 |
Yes | 19,134 | 6.6 | 2738 | 13.5 | |
Don’t know/refusal | 516 | 0.2 | 386 | 1.9 | |
Wearing glasses or contact lenses | |||||
No | 128,205 | 43.9 | 4067 | 20.0 | <0.001 |
Yes | 163,187 | 55.9 | 16,241 | 79.8 | |
Don’t know/refusal | 430 | 0.1 | 42 | 0.2 | |
Physical limitation | |||||
No difficulty | 236,831 | 81.2 | 10,362 | 50.9 | <0.001 |
Moderate difficulty | 24,361 | 8.3 | 4572 | 22.5 | |
Severe difficulty | 15,626 | 5.4 | 4746 | 23.3 | |
Don’t know/refusal | 15,005 | 5.1 | 670 | 3.3 | |
Intensity of bodily pain during the past 4 weeks | |||||
None | 141,928 | 48.6 | 5682 | 27.9 | <0.001 |
Very mild | 37,087 | 12.7 | 2207 | 10.8 | |
Mild | 39,509 | 13.5 | 3062 | 15.0 | |
Moderate | 41,170 | 14.1 | 4916 | 24.2 | |
Severe | 18,307 | 6.3 | 2998 | 14.7 | |
Very severe | 4966 | 1.7 | 985 | 4.8 | |
Don’t know/refusal | 8854 | 3.0 | 500 | 2.5 | |
Depression severity (PHQ-8) | |||||
None/minimal (0–4) | 195,611 | 67.0 | 10,866 | 53.4 | <0.001 |
Mild (5–9) | 33,189 | 11.4 | 3599 | 17.7 | |
Moderate (10–14) | 8451 | 2.9 | 1378 | 6.8 | |
Severe (15–24) | 4807 | 1.6 | 923 | 4.5 | |
Don’t know/refusal | 49,764 | 17.1 | 3584 | 17.6 |
Health Status Variables | OR | 95% CI | p Value |
---|---|---|---|
Self-perceived general health | |||
Very good | 1 | ||
Good | 1.61 | (1.45–1.80) | <0.001 |
Fair | 2.52 | (2.25–2.81) | <0.001 |
Bad | 3.42 | (3.03–3.87) | <0.001 |
Very bad | 3.38 | (2.92–3.91) | <0.001 |
Don’t know/refusal | 1.88 | (1.35–2.60) | <0.001 |
Long-standing health problem (duration ≥ 6 months) | |||
No | 1 | ||
Yes | 7.39 | (6.85–7.97) | <0.001 |
Educational attainment | |||
Tertiary education; bachelor, master or doctoral level | 1 | ||
Tertiary education; short cycle | 0.98 | (0.90–1.08) | 0.752 |
Secondary education | 1.14 | (1.07–1.22) | <0.001 |
Primary education | 1.29 | (1.19–1.41) | <0.001 |
Don’t know/refusal | 1.15 | (0.88–1.50) | 0.306 |
Labor status | |||
In work | 1 | ||
Unemployed | 1.09 | (0.90–1.21) | 0.088 |
Studying | 0.85 | (0.70–1.02) | 0.088 |
Retired | 1.21 | (1.13–1.30) | <0.001 |
Domestic tasks | 1.28 | (1.15–1.43) | <0.001 |
Other inactive | 1.14 | (1.05–1.24) | 0.001 |
Don’t know/refusal | 1.20 | (0.97–1.48) | 0.094 |
Body mass index | |||
Normal | 1 | ||
Overweight | 1.57 | (1.49–1.65) | <0.001 |
Obese | 2.75 | (2.60–2.90) | <0.001 |
Don’t know/refusal | 1.73 | (1.53–1.95) | <0.001 |
Hours of recreational physical activity | |||
> 7 h a week | 1 | ||
3–7 h a week | 1.01 | (0.89–1.15) | 0.821 |
1–3 h a week | 1.04 | (0.93–1.17) | 0.485 |
Don’t know/refusal | 1.14 | (1.02–1.28) | 0.020 |
Frequency of eating fruit | |||
Once or more a day | 1 | ||
4–6 times a week | 0.90 | (0.85–0.95) | <0.001 |
1–3 times a week | 0.86 | (0.814–0.91) | <0.001 |
<once a week | 0.88 | (0.81–0.95) | 0.001 |
Never | 0.81 | (0.68–0.97) | 0.025 |
Don’t know/refusal | 0.74 | (0.53–1.03) | 0.079 |
Household income | |||
Below 1st quintile | 1 | ||
Between 1st and 2nd quintile | 1.09 | (1.03–1.16) | 0.002 |
Between 2nd and 3rd quintile | 1.02 | (0.97–1.09) | 0.412 |
Between 3rd and 4th quintile | 1.01 | (0.95–1.08) | 0.744 |
Between 4th and 5th quintile | 1.00 | (0.93–1.08) | 0.918 |
Don’t know/refusal | 0.97 | (0.88–1.07) | 0.554 |
MI or chronic consequences of MI * | |||
No | 1 | ||
Yes | 1.25 | (1.15–1.36) | <0.001 |
Don’t know/refusal | 1.51 | (1.06–2.16) | 0.023 |
Coronary heart disease or angina pectoris * | |||
No | 1 | ||
Yes | 1.09 | (1.03–1.16) | 0.003 |
Don’t know/refusal | 1.12 | (0.82–1.53) | 0.462 |
Hypertension * | |||
No | 1 | ||
Yes | 1.64 | (1.58–1.71) | <0.001 |
Don’t know/refusal | 1.64 | (1.13–2.39) | 0.009 |
Cirrhosis of the liver * | |||
No | 1 | ||
Yes | 1.97 | (1.68–2.32) | <0.001 |
Don’t know/refusal | 2.94 | (2.03–4.28) | <0.001 |
Kidney problems * | |||
No | 1 | ||
Yes | 1.50 | (1.40–1.61) | <0.001 |
Don’t know/refusal | 1.565 | (1.06–2.30) | 0.022 |
Wearing glasses or contact lenses | |||
No | 1 | ||
Yes | 1.19 | (1.13–1.25) | <0.001 |
Don’t know/refusal | 0.78 | (0.51–1.21) | 0.270 |
Physical limitation | |||
No difficulty | 1 | ||
Moderate difficulty | 1.10 | (1.04–1.15) | <0.001 |
Severe difficulty | 1.19 | (1.12–1.27) | <0.001 |
Don’t know/refusal | 1.16 | (0.83–1.62) | 0.372 |
Intensity of bodily pain during the past 4 weeks | |||
None | 1 | ||
Very mild | 0.87 | (0.83–0.93) | <0.001 |
Mild | 0.76 | (0.71–0.81) | <0.001 |
Moderate | 0.74 | (0.70–0.79) | <0.001 |
Severe | 0.70 | (0.66–0.76) | <0.001 |
Very severe | 0.77 | (0.69–0.86) | <0.001 |
Don’t know/refusal | 0.73 | (0.54–0.98) | 0.039 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Fuentes-Merlos, Á.; Orozco-Beltrán, D.; Quesada Rico, J.A.; Reina, R. Quality-of-Life Determinants in People with Diabetes Mellitus in Europe. Int. J. Environ. Res. Public Health 2021, 18, 6929. https://doi.org/10.3390/ijerph18136929
Fuentes-Merlos Á, Orozco-Beltrán D, Quesada Rico JA, Reina R. Quality-of-Life Determinants in People with Diabetes Mellitus in Europe. International Journal of Environmental Research and Public Health. 2021; 18(13):6929. https://doi.org/10.3390/ijerph18136929
Chicago/Turabian StyleFuentes-Merlos, Álvaro, Domingo Orozco-Beltrán, Jose A. Quesada Rico, and Raul Reina. 2021. "Quality-of-Life Determinants in People with Diabetes Mellitus in Europe" International Journal of Environmental Research and Public Health 18, no. 13: 6929. https://doi.org/10.3390/ijerph18136929
APA StyleFuentes-Merlos, Á., Orozco-Beltrán, D., Quesada Rico, J. A., & Reina, R. (2021). Quality-of-Life Determinants in People with Diabetes Mellitus in Europe. International Journal of Environmental Research and Public Health, 18(13), 6929. https://doi.org/10.3390/ijerph18136929